Browse the evidence

Achieving a total body weight loss of 10-15% (or >10-15 kg) through Total Diet Replacement (TDR) induces remission of Type 2 Diabetes in individuals with short-duration disease.

If you have recently been diagnosed with Type 2 Diabetes, focus on losing 10-15% of your body weight. The most effective way to do this, according to current evidence, is using a Total Diet Replacement program (like liquid formula meals) for 12 weeks, followed by a structured transition to healthy food. This approach is more likely to put your diabetes into remission than low-carb diets or medication alone. Be prepared to work with your doctor to safely stop diabetes medications during the weight loss phase, and have a plan for maintenance support to keep the weight off.

Achieving type 2 diabetes remission requires significant weight loss (≥15 kg) via major caloric restriction, independent of macronutrient composition.

To potentially reverse type 2 diabetes, you need to lose a significant amount of weight, specifically 15 kg or more. This is best achieved through a medically supervised very low-calorie diet (around 800-850 calories/day) for 12-20 weeks, followed by a structured reintroduction of food. The specific type of diet (low-carb vs low-fat) is less important than achieving this weight loss threshold.

Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.

Start with metformin plus either an SGLT-2 inhibitor or a GLP-1 receptor agonist. This combination is proven to protect your heart and kidneys better than older drugs like sulfonylureas. Focus on lifestyle changes like exercise and healthy eating alongside this medication.

For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.

If you have severe, early-onset obesity with hyperphagia, ask your doctor about genetic testing for monogenic causes. If you have a mutation in the leptin-melanocortin pathway (leptin, POMC, PCSK1, or LEPR genes), targeted treatments like setmelanotide or metreleptin can be highly effective, resulting in significant weight loss for many patients.

Bariatric surgery (specifically Sleeve Gastrectomy and Roux-en-Y Gastric Bypass) is an effective treatment for severe obesity and can lead to remission of Type 2 Diabetes, particularly in patients with a short disease duration.

If you have severe obesity (BMI >40 or >35 with health issues), bariatric surgery is a medically recognized option that can potentially reverse Type 2 Diabetes, especially if you have had it for less than 10 years. Discuss this with a specialist to see if you are a candidate.

Bariatric surgery (Metabolic Bariatric Surgery) is the most effective intervention for achieving long-term Type 2 Diabetes remission, with remission rates up to 80% in the first two years, driven by both weight loss and weight-independent hormonal changes.

For individuals with severe obesity and Type 2 Diabetes, bariatric surgery (like Gastric Bypass or Sleeve Gastrectomy) offers the highest chance of remission (up to 80%). It works by restricting food intake and altering gut hormones. It is recommended for those with BMI >= 35, or BMI 30-35 if diabetes is uncontrolled by other means.

For patients with Class III obesity (BMI >39.9 kg/m2), metabolic bariatric surgery (MBS) is significantly more effective than any currently approved medication, with BilioPancreatic Diversion (BPD) showing the highest estimated weight loss.

If you have Class III obesity (BMI >39.9), surgery is the most effective treatment available. Medications like semaglutide are significantly less effective than surgery for this group. If you are not a candidate for surgery or refuse it, medication is still an option, but you should expect less weight loss compared to surgical outcomes.

Bariatric surgery (specifically Roux-en-Y gastric bypass and sleeve gastrectomy) consistently achieves sustained weight loss of 25-30% and improves cardiovascular outcomes, serving as the current gold standard for efficacy.

Bariatric surgery (like RYGB or SG) is the most effective current treatment for obesity, achieving 25-30% sustained weight loss and reducing cardiovascular risk. It works by altering gut hormones to reduce appetite, not just by restricting stomach size.

Supervised exercise training (SET) is the first-line treatment for chronic symptomatic peripheral artery disease (PAD) and intermittent claudication, significantly improving walking distance and functional status.

If you have PAD, supervised walking exercise is your best first treatment. Go to a clinic or program where professionals supervise you. Walk until your leg pain is severe (but not unbearable), rest until it passes, and repeat. Do this at least 3 times a week for 30-60 minutes. This will significantly increase how far you can walk.

Resistance training (RT) is the most effective intervention to prevent, mitigate, and recover from disuse-induced skeletal muscle atrophy in older adults, particularly when combined with adequate protein intake.

To protect your muscles as you age, especially if you have to be inactive for any reason (like surgery or illness), you must do resistance training. Aim for at least two days a week. You don't need heavy weights; resistance bands or bodyweight exercises work well. Focus on doing 1-3 sets of 6-12 repetitions with good effort, and make sure you eat enough protein. This is the best way to keep your strength and independence.

Older adults require higher total protein intakes (1.0–1.5 g/kg/d) and higher EAA/leucine density to overcome anabolic resistance and maximize muscle protein synthesis.

If you are over 65, aim for 1.0 to 1.5 grams of protein per kilogram of body weight daily. Focus on protein sources rich in essential amino acids, especially leucine, to help your muscles respond better to food and exercise. This helps prevent age-related muscle loss.

GLP-1 receptor agonists (GLP1RAs) and SGLT2 inhibitors should be used as first-line treatment in patients with Type 2 Diabetes and initial kidney disease, combined with Metformin.

If you have Type 2 Diabetes and early signs of kidney disease (like high blood pressure or protein in urine), ask your doctor about starting Metformin along with an SGLT2 inhibitor (like Jardiance or Farxiga). If more treatment is needed, a GLP-1 receptor agonist (like Ozempic or Trulicity) can be added. This combination is now recommended as the best way to protect your kidneys and heart.

Comprehensive lifestyle intervention combining a daily caloric deficit of 500-1,000 kcal, aerobic exercise of ≥150 minutes per week, and resistance training 2-4 times per week is the foundational, evidence-based standard for obesity management.

Start by cutting 500-1,000 calories daily and aim for 150 minutes of moderate cardio (like brisk walking) spread over 3-5 days. Add 2-4 days of strength training using major muscle groups. Crucially, engage in behavioral counseling (tracking food, setting goals) for at least 6 months to ensure you stick with it.

Bariatric surgery (gastric bypass, sleeve gastrectomy, duodenal switch) is the most effective intervention for significant weight loss and metabolic benefits in severe obesity.

For severe obesity, bariatric surgery (like gastric bypass or sleeve gastrectomy) is the most effective way to achieve significant weight loss. It works by restricting stomach size and/or altering digestion. It also improves metabolic health. Recovery is faster with modern laparoscopic techniques.

Semaglutide 2.4 mg once weekly is a highly effective treatment for obesity, leading to an average 14.9% body weight loss in nondiabetic adults over 68 weeks, and reduces major adverse cardiovascular events (MACE) in patients with obesity without diabetes.

Semaglutide 2.4 mg once weekly is a powerful treatment for obesity. In clinical trials, it helped people lose nearly 15% of their body weight. It also reduces the risk of major cardiovascular events in people with obesity but no diabetes. Discuss with your doctor if this once-weekly injection is right for you.

Traditional heavy resistance exercise training increases maximal strength.

Practitioners should incorporate traditional heavy resistance training to enhance maximal strength.

Metabolic and bariatric surgeries are the most effective strategy for significant weight loss in people living with severe obesity.

This reinforces the importance of considering surgical options for significant weight loss in severely obese patients.

Lifestyle interventions, including dietary modifications and increased physical activity, are essential for obesity management.

Practitioners should incorporate lifestyle changes into obesity treatment plans.

For the treatment of obesity, a negative energy balance is crucial.

Weight loss strategies should focus on achieving a negative energy balance.

Bariatric and metabolic surgery (BMS) is the most effective intervention for achieving significant and sustained weight loss, with mean excess weight loss (EWL) of 53% for sleeve gastrectomy (SG) and 63% for Roux-en-Y gastric bypass (RYGB) over 5 years.

Practitioners should consider BMS as a primary option for patients needing significant weight loss.

Most athletes ideally need 1.2 to 2.0 grams/kg of body weight/day of protein, preferably split across 3-4 meals.

Athletes should aim for a specific protein intake range to enhance muscle synthesis and recovery.

Bariatric surgery is the most effective long-term treatment for obesity, with an average weight loss of 30-40%.

Bariatric surgery should be considered for eligible patients as a highly effective long-term weight loss solution.

Caloric restriction leads to a significant decrease in body weight in the short term.

Practitioners should consider caloric restriction as an effective short-term strategy for weight loss.

Lifestyle interventions (diet and exercise) remain the most cost-effective and durable strategy for weight loss and diabetes prevention, outperforming microbiome therapies in long-term weight management.

Diet and exercise are the most effective and affordable way to lose weight and prevent diabetes. They outperform probiotics and FMT for weight loss and provide durable benefits.